These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8396762)

  • 1. Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II.
    Brou C; Kuhn A; Staub A; Chaudhary S; Grummt I; Davidson I; Tora L
    Nucleic Acids Res; 1993 Aug; 21(17):4011-8. PubMed ID: 8396762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA topoisomerase I is involved in both repression and activation of transcription.
    Merino A; Madden KR; Lane WS; Champoux JJ; Reinberg D
    Nature; 1993 Sep; 365(6443):227-32. PubMed ID: 8396729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
    Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
    Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of RNA polymerase I-directed transcription by novobiocin. Potential use of novobiocin as a general inhibitor of eukaryotic transcription initiation.
    Webb ML; Jacob ST
    J Biol Chem; 1988 Apr; 263(10):4745-8. PubMed ID: 2832404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the association of RNA polymerase II with the preinitiation complex by a viral transcriptional repressor.
    Lee G; Wu J; Luu P; Ghazal P; Flores O
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2570-5. PubMed ID: 8637915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II.
    Kretzschmar M; Meisterernst M; Roeder RG
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11508-12. PubMed ID: 8265582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II.
    Espinoza JA; Kanellis DC; Saproo S; Leal K; Martinez JF; Bartek J; Lindström MS
    Nucleic Acids Res; 2024 May; 52(8):4151-4166. PubMed ID: 38340348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II.
    Gottesfeld JM
    Nucleic Acids Res; 1986 Mar; 14(5):2075-88. PubMed ID: 3008085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novobiocin inhibits initiation of RNA polymerase II-directed transcription of the mouse metallothionein-I gene independent of its effect on DNA topoisomerase II.
    Webb ML; Maguire KA; Jacob ST
    Nucleic Acids Res; 1987 Oct; 15(20):8547-60. PubMed ID: 2823231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and III.
    Schaub M; Myslinski E; Schuster C; Krol A; Carbon P
    EMBO J; 1997 Jan; 16(1):173-81. PubMed ID: 9009278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerase IIalpha is required for RNA polymerase II transcription on chromatin templates.
    Mondal N; Parvin JD
    Nature; 2001 Sep; 413(6854):435-8. PubMed ID: 11574892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcription.
    Croston GE; Kerrigan LA; Lira LM; Marshak DR; Kadonaga JT
    Science; 1991 Feb; 251(4994):643-9. PubMed ID: 1899487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TBP-TAF complex required for transcription of human snRNA genes by RNA polymerase II and III.
    Henry RW; Sadowski CL; Kobayashi R; Hernandez N
    Nature; 1995 Apr; 374(6523):653-6. PubMed ID: 7715707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY; Beck WT
    Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase IIα promotes activation of RNA polymerase I transcription by facilitating pre-initiation complex formation.
    Ray S; Panova T; Miller G; Volkov A; Porter AC; Russell J; Panov KI; Zomerdijk JC
    Nat Commun; 2013; 4():1598. PubMed ID: 23511463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Cellular RNA polymerase II transcription by delta antigen of hepatitis delta virus.
    Lo K; Sheu GT; Lai MM
    Virology; 1998 Aug; 247(2):178-88. PubMed ID: 9705911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinjection of anti-topoisomerase I immunoglobulin G into nuclei of Chironomus tentans salivary gland cells leads to blockage of transcription elongation.
    Egyházi E; Durban E
    Mol Cell Biol; 1987 Dec; 7(12):4308-16. PubMed ID: 2449604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions.
    Shaiu WL; Hu T; Hsieh TS
    Pac Symp Biocomput; 1999; ():578-89. PubMed ID: 10380229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
    Ju BG; Lunyak VV; Perissi V; Garcia-Bassets I; Rose DW; Glass CK; Rosenfeld MG
    Science; 2006 Jun; 312(5781):1798-802. PubMed ID: 16794079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.